Anti-Cancer Patent Refusal Set Aside for Not Identifying ‘Known Substance’
In a recent ruling, the Delhi High Court overturned the rejection of an anti-cancer patent filed by Taiho Pharmaceutical. The Court highlighted that objections under Section 3(d) must…